Clinical evaluation of Siddha medicine elathi chooranam for the management of hypertension

Phase 2

Not yet recruiting

• Conditions: Essential (primary) hypertension,

• Registration Number: CTRI/2021/11/037810
• Lead Sponsor: Government Siddha Medical College

Brief Summary

This is single Non randomized open clinical trial to study the safety and efficacy of siddha trial drug ELATHI CHOORANAM. The trial drug is given 5grams twice a day for 48 days. Clinical trial is conducted after conducting pre clinical toxicity study. The trial drug ELATHI CHOORANAM is mentioned in sarabenthira vaithiya muraikal. During the trial all the study related data will be recorded and documented. After the completion of the trial all the data will be analysed statistically

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2021-10-29
• Study Start: 2021-11-11

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Primary hypertension Giddiness Sweating Nausea Headache Fatigue Blood pressure level140/90mmhg.

Exclusion Criteria

Secondary hypertension Hypertension in pregnancy Hypertension with diabetes mellitus Blood pressure above 180/100.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome is mainly assessed by reducing blood pressure up to 10-20 mmHg systolic and 5-10 mmhg in diastolic level	48days

Secondary Outcome Measures

Name	Time	Method
Secondary outcome is assessed by comparing the safety parameters before and after treatment	48 days

Trial Locations

Locations (1)

Arignar Anna Hospital of Indian Medicine and Homoeopathy; 🇮🇳 Chennai, TAMIL NADU, India

Arignar Anna Hospital of Indian Medicine and Homoeopathy

🇮🇳Chennai, TAMIL NADU, India

SDinesh kumar

Principal investigator

6379266336

gulludinesh1995@gmail.com